Tế bào T Biểu hiện Thụ thể Kháng nguyên Chimera Bispecific CD19/CD20 Ngăn chặn Sự Trốn thoát Kháng nguyên của Tế bào B Ác tính

Kalos, 2013, Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology, Immunity, 39, 49, 10.1016/j.immuni.2013.07.002

Rosenberg, 2015, Adoptive cell transfer as personalized immunotherapy for human cancer, Science, 348, 62, 10.1126/science.aaa4967

Kalos, 2011, T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia, Sci Transl Med, 3, 95ra73, 10.1126/scitranslmed.3002842

Porter, 2011, Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia, N Engl J Med, 365, 725, 10.1056/NEJMoa1103849

Brentjens, 2013, CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia, Sci Transl Med, 5, 177ra38, 10.1126/scitranslmed.3005930

Kochenderfer, 2012, B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells, Blood, 119, 2709, 10.1182/blood-2011-10-384388

Grupp, 2013, Chimeric antigen receptor-modified T cells for acute lymphoid leukemia, N Engl J Med, 368, 1509, 10.1056/NEJMoa1215134

Davila, 2014, Efficacy and toxicity management of 19–28z CAR T cell therapy in B cell acute lymphoblastic leukemia, Sci Transl Med, 6, 224ra25, 10.1126/scitranslmed.3008226

Kochenderfer, 2015, Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor, J Clin Oncol, 33, 540, 10.1200/JCO.2014.56.2025

Maude, 2014, Chimeric antigen receptor T cells for sustained remissions in leukemia, N Engl J Med, 371, 1507, 10.1056/NEJMoa1407222

Rapoport, 2015, NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma, Nat Med, 21, 914, 10.1038/nm.3910

Jager, 1996, Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo, Int J Cancer, 66, 470, 10.1002/(SICI)1097-0215(19960516)66:4<470::AID-IJC10>3.0.CO;2-C

Riker, 1999, Immune selection after antigen-specific immunotherapy of melanoma, Surgery, 126, 112, 10.1016/S0039-6060(99)70143-1

Grada, 2013, TanCAR: A novel bispecific chimeric antigen receptor for cancer immunotherapy, Mol Ther Nucleic Acids, 2, e105, 10.1038/mtna.2013.32

Gibson, 2009, Enzymatic assembly of DNA molecules up to several hundred kilobases, Nat Methods, 6, 343, 10.1038/nmeth.1318

Nicholson, 1997, Construction and characterisation of a functional CD19 specific single chain Fv fragment for immunotherapy of B lineage leukaemia and lymphoma, Mol Immunol, 34, 1157, 10.1016/S0161-5890(97)00144-2

Jensen, 1998, CD20 is a molecular target for scFvFc:zeta receptor redirected T cells: implications for cellular immunotherapy of CD20+ malignancy, Biol Blood Marrow Transplant, 4, 75, 10.1053/bbmt.1998.v4.pm9763110

Wang, 2011, A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells, Blood, 118, 1255, 10.1182/blood-2011-02-337360

Pelloquin, 1986, Human B lymphocytes immortalization by Epstein-Barr virus in the presence of cyclosporin A, In Vitro Cell Dev Biol, 22, 689, 10.1007/BF02621085

Riddell, 1990, The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells, J Immunol Methods, 128, 189, 10.1016/0022-1759(90)90210-M

Hudecek, 2015, The nonsignaling extracellular spacer domain of chimeric antigen receptors is decisive for in vivo antitumor activity, Cancer Immunol Res, 3, 125, 10.1158/2326-6066.CIR-14-0127

Arai, 2001, Design of the linkers which effectively separate domains of a bifunctional fusion protein, Protein Eng, 14, 529, 10.1093/protein/14.8.529

Arai, 2004, Conformations of variably linked chimeric proteins evaluated by synchrotron X-ray small-angle scattering, Proteins, 57, 829, 10.1002/prot.20244

Chang, 2015, Identification and selective expansion of functionally superior T cells expressing chimeric antigen receptors, J Transl Med, 13, 161, 10.1186/s12967-015-0519-8

Boye, 2003, An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab, Ann Oncol, 14, 520, 10.1093/annonc/mdg175

Till, 2012, CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results, Blood, 119, 3940, 10.1182/blood-2011-10-387969

Otero, 2003, CD19 function in early and late B cell development: I. Maintenance of follicular and marginal zone B cells requires CD19-dependent survival signals, J Immunol, 170, 73, 10.4049/jimmunol.170.1.73

Tedder, 1994, CD20: A regulator of cell-cycle progression of B lymphocytes, Immunol Today, 15, 450, 10.1016/0167-5699(94)90276-3

Hegde, 2013, Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma, Mol Ther, 21, 2087, 10.1038/mt.2013.185

Anurathapan, 2014, Kinetics of tumor destruction by chimeric antigen receptor-modified T cells, Mol Ther, 22, 623, 10.1038/mt.2013.262

Bos, 2010, Large double copy vectors are functional but show a size-dependent decline in transduction efficiency, J Biotechnol, 150, 37, 10.1016/j.jbiotec.2010.07.010

Kumar, 2001, Systematic determination of the packaging limit of lentiviral vectors, Hum Gene Ther, 12, 1893, 10.1089/104303401753153947

Zhou, 2015, Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation, Blood, 125, 4103, 10.1182/blood-2015-02-628354

Fedorov, 2013, PD-1- and CTLA-4-based inhibitory chimeric antigen receptors (iCARs) divert off-target immunotherapy responses, Sci Transl Med, 5, 215ra172, 10.1126/scitranslmed.3006597

Gill, 2015, Going viral: Chimeric antigen receptor T-cell therapy for hematological malignancies, Immunol Rev, 263, 68, 10.1111/imr.12243

Long, 2015, 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors, Nat Med, 21, 581, 10.1038/nm.3838

Tedder, 1989, Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes. A new member of the immunoglobulin superfamily, J Immunol, 143, 712, 10.4049/jimmunol.143.2.712

Einfeld, 1988, Molecular cloning of the human B cell CD20 receptor predicts a hydrophobic protein with multiple transmembrane domains, EMBO J, 7, 711, 10.1002/j.1460-2075.1988.tb02867.x

Till, 2008, Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells, Blood, 112, 2261, 10.1182/blood-2007-12-128843

Weimer, 2008, Prolonged in-vivo half-life of factor VIIa by fusion to albumin, Thromb Haemost, 99, 659, 10.1160/TH07-08-0525

Zollner, 2014, Pharmacological characteristics of a novel, recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP), J Thromb Haemost, 12, 220, 10.1111/jth.12477

Guest, 2005, The role of extracellular spacer regions in the optimal design of chimeric immune receptors: evaluation of four different scFvs and antigens, J Immunother, 28, 203, 10.1097/01.cji.0000161397.96582.59

Hudecek, 2013, Receptor affinity and extracellular domain modifications affect tumor recognition by ROR1-specific chimeric antigen receptor T cells, Clin Cancer Res, 19, 3153, 10.1158/1078-0432.CCR-13-0330

Frigault, 2015, Identification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T cells, Cancer Immunol Res, 3, 356, 10.1158/2326-6066.CIR-14-0186

Kunkele, 2015, Functional tuning of CARs reveals signaling threshold above which CD8+ CTL antitumor potency is attenuated due to cell fas-FasL-Dependent AICD, Cancer Immunol Res, 3, 368, 10.1158/2326-6066.CIR-14-0200